Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ: TELA )

2.910 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TELA Bio, Inc. - Common stock

< Previous 1 2 3 4 Next >
Recap: TELA Bio Q4 Earnings
Via Benzinga
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
Strong and secure, LIQUIFIX is the first approved adhesive-based product to affix mesh without penetrating patient tissue 
From TELA Bio, Inc.
Via GlobeNewswire
Preview: TELA Bio's Earnings
Via Benzinga
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
TELA Bio to receive at least $8 million and up to $12 million in total consideration 
From TELA Bio, Inc.
Via GlobeNewswire
Recap: TELA Bio Q3 Earnings
Via Benzinga
Recap: TELA Bio Q1 Earnings
Via Benzinga
Earnings Scheduled For March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Take Part in Connecting the Dots
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
TELA Bio Reports Third Quarter 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Announce Third Quarter 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
From TELA Bio, Inc.
Via GlobeNewswire
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
New addition expands reconstruction options for surgeons and patients 
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Reports Second Quarter 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Participate in the Jefferies Global Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
Company prioritizes education with a variety of in-person and virtual training programs 
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Reports First Quarter 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Earnings Scheduled For May 11, 2023
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its... 
Via Benzinga
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
Leader in innovative soft-tissue tissue reconstruction solutions sponsors event advocating for and mentoring women in surgery 
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Participate in the JMP Securities Life Sciences Conference
From TELA Bio, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.